Patellamide D (patH4), a cyclic octapeptide from the ascidian Lissoclinum patella, with two oxazoline and two thiazole rings, has the 24-azacrown-8 macrocyclic structure. The cyclic octapeptide forms multiple mononuclear copper(II) complexes in which there are three nitrogen ligating atoms, arising from a deprotonated amide and oxazoline and thiazole rings, coordinated to the copper(II) ion. The multiple mononuclear copper(II) complexes can be ascribed to different metal binding sites in patH4; there are four in the asymmetric patH4 molecule and the binding of different ligands (Cl- or H2O) to the fourth equatorial coordination site. Patellamide D also forms three binuclear copper(II) complexes ([Cu2(patH2)]2+, [Cu2(patH2)(OH)]+, and [CU2(patH2)(CO3)]) in which each copper(II) ion is coordinated by three nitrogen ligating atoms from a deprotonated amide and oxazoline and thiazole rings. The remaining coordination sites may be occupied by either Cl- or H2O in the first two complexes, while carbonate is assumed, on the basis of X-my crystallography presented in a future paper, to bridge the two copper(II) ions in the third complex. Electronic absorption, circular dichroism, electron paramagnetic resonance, and mass spectra are reported as a function of the concentration of base added to the copper(II) patellamide solutions.
No takes yet. Share an insight, caveat, or question.
Brenk et al. (1994) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: